Crossover Study With MultiHance vs a Comparator for Peripheral MRA

NCT00408083 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Vascular Disease

Interventions

DRUG: MultiHance
DRUG: Magnevist

Sponsor

Bracco Diagnostics, Inc